Carbidopa/Levodopa Fair-Med

Medicinal product

(Invented) name

Carbidopa/Levodopa Fair-Med

Active substance (s)

Karbidopa/Levodopa

Strength

25 mg/100 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N04BA02, Levodopa and decarboxylase inhibitor

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-07-14

Date of renewal

Documents

3525_Carbidopa_Levodopa Fair-Med 25_100mg_tab_PL_2026-07-14.docx

3525_Carbidopa_Levodopa Fair-Med 25_100mg_tab_PZ_2026-07-14.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Karbidopa	25 mg
Levodopa	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121516	107623	1107623	lizdinė plokštelė	N100		Receptinis	LT/L/26/3525/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-07-14	Registruotas